Literature DB >> 25006391

Coagulation and the vessel wall in pulmonary embolism.

Sherin Alias1, Irene M Lang1.   

Abstract

Venous thromboembolism comprises deep-vein thrombosis, thrombus in transit, acute pulmonary embolism, and chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary thromboemboli commonly resolve, with restoration of normal pulmonary hemodynamics. When they fail to resorb, permanent occlusion of the deep veins and/or CTEPH are the consequences. Apart from endogenous fibrinolysis, venous thrombi resolve by a process of mechanical fragmentation, through organization of the thromboembolus by invasion of endothelial cells, leukocytes, and fibroblasts leading to recanalization. Recent data utilizing various models have contributed to a better understanding of venous thrombosis and the resolution process that is directed at maintaining vascular patency. This review summarizes the plasmatic and cellular components of venous thrombus formation and resolution.

Entities:  

Keywords:  CTEPH; pulmonary embolism; thrombosis; thrombus resolution

Year:  2013        PMID: 25006391      PMCID: PMC4070824          DOI: 10.1086/674768

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  125 in total

1.  Chronic thromboembolic pulmonary hypertension--not so rare after all.

Authors:  Irene M Lang
Journal:  N Engl J Med       Date:  2004-05-27       Impact factor: 91.245

Review 2.  Chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; W R Auger; P F Fedullo
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

Review 3.  Expression of fibrinolytic genes in tissues from human atherosclerotic aneurysms and from obese mice.

Authors:  F Samad; J Schneiderman; D Loskutoff
Journal:  Ann N Y Acad Sci       Date:  1997-04-15       Impact factor: 5.691

4.  Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells.

Authors:  Andreas E May; Thorsten Kälsch; Steffen Massberg; Yared Herouy; Roland Schmidt; Meinrad Gawaz
Journal:  Circulation       Date:  2002-10-15       Impact factor: 29.690

Review 5.  Epidemiology and risk factors for venous thrombosis.

Authors:  Mary Cushman
Journal:  Semin Hematol       Date:  2007-04       Impact factor: 3.851

6.  Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism.

Authors:  Sulaiman Surie; Nadine S Gibson; Victor E A Gerdes; Berto J Bouma; Berthe L F van Eck-Smit; Harry R Buller; Paul Bresser
Journal:  Thromb Res       Date:  2010-01-20       Impact factor: 3.944

7.  Role for staphylococci in misguided thrombus resolution of chronic thromboembolic pulmonary hypertension.

Authors:  Diana Bonderman; Johannes Jakowitsch; Bassam Redwan; Helga Bergmeister; Maria-Klara Renner; Heidi Panzenböck; Christopher Adlbrecht; Apostolos Georgopoulos; Walter Klepetko; Meinhard Kneussl; Irene M Lang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-31       Impact factor: 8.311

8.  Fibrin resistance to lysis in patients with pulmonary hypertension other than thromboembolic.

Authors:  Massimo Miniati; Claudia Fiorillo; Matteo Becatti; Simonetta Monti; Matteo Bottai; Carlo Marini; Elisa Grifoni; Bruno Formichi; Carolina Bauleo; Chiara Arcangeli; Daniela Poli; Paolo Antonio Nassi; Rosanna Abbate; Domenico Prisco
Journal:  Am J Respir Crit Care Med       Date:  2010-01-14       Impact factor: 21.405

9.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

10.  Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.

Authors:  S Lindemann; N D Tolley; D A Dixon; T M McIntyre; S M Prescott; G A Zimmerman; A S Weyrich
Journal:  J Cell Biol       Date:  2001-08-06       Impact factor: 10.539

View more
  9 in total

1.  Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.

Authors:  F N Rahaghi; J C Ross; M Agarwal; G González; C E Come; A A Diaz; G Vegas-Sánchez-Ferrero; A Hunsaker; R San José Estépar; A B Waxman; G R Washko
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

2.  Gene Expression Profiling of Pulmonary Artery in a Rabbit Model of Pulmonary Thromboembolism.

Authors:  Zhiyuan Tang; Xudong Wang; Jianfei Huang; Xiaoyu Zhou; Hao Xie; Qilin Zhu; Minjie Huang; Songshi Ni
Journal:  PLoS One       Date:  2016-10-31       Impact factor: 3.240

3.  Role of FoxO1 and apoptosis in pulmonary vascular remolding in a rat model of chronic thromboembolic pulmonary hypertension.

Authors:  Chaosheng Deng; Zhanghua Zhong; Dawen Wu; Yunfei Chen; Ningfang Lian; Haibo Ding; Qiaoxian Zhang; Qichang Lin; Shuang Wu
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

Review 4.  Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives.

Authors:  Chao Yan; Xiaohua Wang; Hua Su; Kejing Ying
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

5.  Pulmonary Arterial Hypertension and Endothelial Dysfunction Is Linked to NADPH Oxidase-Derived Superoxide Formation in Venous Thrombosis and Pulmonary Embolism in Mice.

Authors:  Moritz Brandt; Eleni Giokoglu; Venkata Garlapati; Madgalena L Bochenek; Michael Molitor; Lukas Hobohm; Tanja Schönfelder; Thomas Münzel; Sabine Kossmann; Susanne H Karbach; Katrin Schäfer; Philip Wenzel
Journal:  Oxid Med Cell Longev       Date:  2018-06-10       Impact factor: 6.543

6.  Phospholipid membranes drive abdominal aortic aneurysm development through stimulating coagulation factor activity.

Authors:  Keith Allen-Redpath; Maceler Aldrovandi; Sarah N Lauder; Anastasia Gketsopoulou; Victoria J Tyrrell; David A Slatter; Robert Andrews; W John Watkins; Georgia Atkinson; Eileen McNeill; Anna Gilfedder; Majd Protty; James Burston; Sam R C Johnson; Patricia R S Rodrigues; Dylan O Jones; Regent Lee; Ashok Handa; Keith Channon; Samya Obaji; Jorge Alvarez-Jarreta; Gerhard Krönke; Jochen Ackermann; P Vince Jenkins; Peter W Collins; Valerie B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-03       Impact factor: 11.205

7.  Description, Staging and Quantification of Pulmonary Artery Angiophagy in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Frédéric Perros; Maria-Rosa Ghigna; Fanny Loisel; Denis Chemla; Benoit Decante; Vincent de Montpreville; David Montani; Marc Humbert; Elie Fadel; Olaf Mercier; David Boulate
Journal:  Biomedicines       Date:  2020-11-11

Review 8.  Resolution of Deep Venous Thrombosis: Proposed Immune Paradigms.

Authors:  J Matthew Nicklas; Aviva E Gordon; Peter K Henke
Journal:  Int J Mol Sci       Date:  2020-03-18       Impact factor: 5.923

9.  Structural and Binding Effects of Chemical Modifications on Thrombin Binding Aptamer (TBA).

Authors:  Vibhav Valsangkar; Sweta Vangaveti; Goh Woon Lee; Walid M Fahssi; Waqas S Awan; Yicheng Huang; Alan A Chen; Jia Sheng
Journal:  Molecules       Date:  2021-07-30       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.